Profile: BioScrip Inc (BIOS.OQ)
8 Dec 2016
BioScrip, Inc., incorporated on March 22, 1996, is engaged in providing infusion solutions. The Company partners with physicians, hospital systems, skilled nursing facilities, healthcare payors and pharmaceutical manufacturers to provide patients access to post-acute care services. The Company operates through Infusion Services segment. The Company operates through approximately 70 service locations in over 30 states. The Company offers home infusion services to provide clinical management services and the delivery of prescription medications.
The Company's platform provides service capabilities to deliver clinical management services that offer patients a community-based and home-based care environment. The Company provides services in coordination with, and under the direction of, the patient's physician. The Company's multidisciplinary team of clinicians, including pharmacists, nurses, dietitians and respiratory therapists, work with the physician to develop a plan of care suited to the patient's specific needs. The Company provides products, services and condition-specific clinical management programs to the individuals with health conditions, such as gastrointestinal abnormalities, infectious diseases, cancer, multiple sclerosis, organ and blood cell transplants, bleeding disorders, immune deficiencies and heart failure. The Company provides the services at home, physician office, ambulatory infusion center, skilled nursing facility or other alternate sites of care.
The Company competes with Option Care, CVS Health, Express Scripts Holding Company and UnitedHealthcare Group.
1600 Broadway Ste 950
DENVER CO 80202-4970
Company Web Links
- BRIEF-Bioscrip reports third quarter 2016 financial results
- BRIEF-Bioscrip files for offering of up to 3.75 mln shares of common stock by the selling stockholder
- BRIEF-Bioscrip And Home Solutions enter deal to expedite closing
- BRIEF-Bioscrip enters into a tax asset protection plan
- BRIEF-North Tide Capital Master reports a passive stake of 7.5 pct in Bioscrip Inc